PRESS RELEASE published on 01/14/2025 at 17:45, 1 year 9 months ago ABEO prolonge son partenariat avec la FIBA jusqu'en 2028 - La marque SCHELDE SPORTS équipera, entre autres, la Coupe du Monde de Basket-Ball FIBA 2027 et les épreuves de Basket-Ball des JO de Los Angeles 2028 ABEO annonce le renouvellement de sa marque SCHELDE SPORTS comme fournisseur officiel mondial de la FIBA jusqu'en 2028, renforçant ainsi leur partenariat stratégique dans le basket-ball international Partenariat Basket-ball ABEO FIBA SCHELDE SPORTS
PRESS RELEASE published on 01/14/2025 at 17:45, 1 year 9 months ago ABEO and FIBA extend partnership until 2028 - SCHELDE SPORTS brand will supply the FIBA Basketball World Cup 2027 and the Los Angeles 2028 Basketball Olympic Tournaments ABEO announces SCHELDE SPORTS as FIBA Global Supplier for backstop units until 2028. SCHELDE SPORTS continues to play a strategic role in international basketball ABEO FIBA SCHELDE SPORTS Backstop Units International Basketball
PRESS RELEASE published on 01/14/2025 at 17:45, 1 year 9 months ago Cibox : Doublement du chiffre d'affaires en 2024 CIBOX, expert français de la micro-mobilité électrique, double son chiffre d'affaires en 2024 avec +104%. Ouverture du site de production définitif à Revin en 2025 Chiffre D'affaires Stratégie Commerciale CIBOX Micro-mobilité Électrique Revin
PRESS RELEASE published on 01/14/2025 at 17:45, 1 year 9 months ago Informations privilégiées / Autres communiqués Verimatrix annonce le lancement de DVB ReAccess, une solution CAS over-the-air. L'audit Farncombe Security® de Cartesian a été réussi VERIMATRIX DVB ReAccess CAS Farncombe Security Cartesian
PRESS RELEASE published on 01/14/2025 at 17:44, 1 year 9 months ago VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE Valbiotis announces success of phase II/III HEART II study on LIPIDRIVE, proving efficacy in reducing LDL cholesterol for mild to moderate hypercholesterolemia. Study validates safety & compliance of Lipidrive Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
PRESS RELEASE published on 01/14/2025 at 17:44, 1 year 9 months ago VALBIOTIS SA: Valbiotis annonce le large succès de l’étude clinique de phase II/III HEART II sur LIPIDRIVE Valbiotis annonce le large succès de l'étude clinique de phase II/III HEART II sur LIPIDRIVE, démontrant l'efficacité sur la réduction du LDL Cholestérol. L'étude confirme l'approche scientifique innovante de Valbiotis Valbiotis Santé Efficacité Étude Clinique LDL Cholesterol
REGULATED PRESS RELEASE published on 01/14/2025 at 17:40, 1 year 9 months ago Infotel : Déclaration des transactions sur actions propres réalisées du 6 au 10 janvier 2025 dans le cadre du programme de rachat d’actions. Communiqué de presse déclarant les transactions sur actions propres d'Infotel du 6 au 10 janvier 2025 dans le cadre du programme de rachat d'actions, consultables sur leur site internet Transactions Sur Actions Propres INFOTEL Programme De Rachat D'actions Euronext B Transformations Digitales
PRESS RELEASE published on 01/14/2025 at 17:20, 1 year 9 months ago 5E Advanced Materials Announces Funding Package and Proposed Restructure and Equitization of Convertible Notes 5E Advanced Materials, Inc. announces a $30 million Transaction and RSA with primary lenders to strengthen balance sheet and progress to Final Investment Decision (FID) Transaction Balance Sheet 5E Advanced Materials Funding Package Restructuring Support Agreement
PRESS RELEASE published on 01/14/2025 at 17:03, 1 year 9 months ago EQS-Adhoc: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture Eckert & Ziegler SE signs licence agreement with Chinese joint venture for Ac-225 cyclotron technology, aiming to increase supply of Ac-225 for radiopharmaceutical industry Radiopharmaceutical Industry Eckert & Ziegler SE Licence Agreement Ac-225 Chinese Joint Venture
PRESS RELEASE published on 01/14/2025 at 16:30, 1 year 9 months ago Holding(s) in Company Morgan Stanley discloses an increase in voting rights in Britvic plc according to regulatory notification TR-1 on 14-Jan-2025 Voting Rights Britvic Plc TR-1 Notification Shareholding Morgan Stanley
Published on 11/04/2026 at 23:10, 8 hours 47 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 8 hours 57 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 9 hours 42 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 9 hours 52 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 07:48, 9 minutes ago IVU Traffic Technologies AG Continues Profitable Growth – EBIT Up 56% y/y in 9M 2026
Published on 11/05/2026 at 07:30, 27 minutes ago Fielmann Group accelerates Q3 sales growth to 5.1%, supported by price leadership and network expansion
Published on 11/05/2026 at 07:30, 27 minutes ago Mayr-Melnhof Karton AG: MM Trading Statement for the first three quarters of 2026
Published on 11/05/2026 at 07:30, 27 minutes ago Deutsche Beteiligungs AG: High transaction activity, recovery in valuation multiples and forecast confirmed
Published on 11/05/2026 at 07:30, 27 minutes ago Q3 2026: ElringKlinger improves key financial metrics and makes further progress in its transformation
Published on 11/05/2026 at 07:00, 57 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 07:00, 57 minutes ago Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Published on 11/05/2026 at 07:00, 57 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%